Tudor Investment Corporation »

Abeona Therapeutics shares owned by Tudor Investment Corporation

Quarter-by-quarter ownership of Abeona Therapeutics (ABEO) shares owned by Tudor Investment Corporation from 13F filings

Historical chart of Tudor Investment Corporation investment in Abeona Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Abeona Therapeutics held by Tudor Investment Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abeona Therapeutics by Tudor Investment Corporation

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.2M 361k 6.18

More positions owned by Tudor Investment Corporation

Ishares Russell 2000 Etf - US ETP ETF Option Call Option (IWM)
Invesco Qqq Trust Series 1 - US ETP ETF Option Call Option (QQQ)
Taiwan Semiconductor Manufacturing Co Ltd - US Depository Receipt (TSM)
Spdr Gold Shares - US ETP ETF Option Call Option (GLD)
Nvidia Corp - US Equity (NVDA)
Micron Technology Inc - US Equity (MU)
Microsoft Corp - US Equity (MSFT)
Ishares Core S&P 500 Etf - US ETP ETF Option Call Option (IVV)
Tesla Inc - US Equity (TSLA)
Ishares Iboxx High Yield Corporate Bond Etf - US E ETF Option Put Option (HYG)
State Street Energy Select Sector SPDR ETF - US ET ETF Option Call Option (XLE)
State Street Financial Select Sector SPDR ETF - US ETF Option Call Option (XLF)
Ishares Msci Emerging Markets Etf - US ETP ETF Option Call Option (EEM)
Advanced Micro Devices Inc - US Equity (AMD)
Amazon.Com Inc - US Equity (AMZN)

View all positions for Tudor Investment Corporation

Top funds holding Abeona Therapeutics

Nantahala Capital Management
BlackRock
Cable Car Capital
AIGH Capital Management
Vanguard Capital Management
Resources Investment Advisors
AWM Investment Company
Geode Capital Management
Kennedy Capital Management
Goldman Sachs Group
Propel Bio Management
State Street Corporation
Nan Fung Trinity
Diametric Capital
J. Goldman & Co

View all funds holding Abeona Therapeutics